Indole

Indole

SCHEMBL463563

c1ccc2[nH]ccc2c1.c1ncncn1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 8/20 0.77
CA1 P00915 2/20 0.77
CA4 P22748 2/20 0.77
CA6 P23280 2/20 0.77
TRPA1 O75762 1/20 0.77
CA2 P00918 1/20 0.77
ITGB2 P05107 1/20 0.77
ICAM1 P05362 1/20 0.77
ITGAL P20701 1/20 0.77
ADK P55263 1/20 0.77
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.40
NR4A2 P43354 2/20 0.39
CYP2A6 P11509 1/20 0.39
CMA1 P23946 1/20 0.39
F7 P08709 1/20 0.39
LTA4H P09960 1/20 0.39
F3 P13726 1/20 0.39
PARP1 P09874 1/20 0.39
TYR P14679 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Indole SCHEMBL28940073 0.91 AHR (0.71) AHRCA1CA4CA6TRPA1
Indole SCHEMBL2487163 0.91 AHR (0.71) AHRCA1CA4CA6TRPA1
Indole SCHEMBL14834292 0.90 AHR (0.68) AHRCA1CA4CA6TRPA1
Indole SCHEMBL30463845 0.88
Indole SCHEMBL30250492 0.88
Indole SCHEMBL28071644 0.88 AHR (1.00) AHRCA1CA4CA6TRPA1
Indole SCHEMBL29352896 0.88
Indole SCHEMBL1160186 0.88 AHR (1.00) AHRCA1CA4CA6TRPA1
Indole SCHEMBL698 0.88
Indole SCHEMBL27393259 0.86 AHR (0.77) AHRCA1CA4CA6TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190135718-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2019-05-09 US disclosed
US-10059664-B2 Sepiapterin reductase inhibitors for the treatment of pain CHILDREN'S MEDICAL CENTER CORPORATION (US) 2018-08-28 US disclosed
US-20170305824-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2017-10-26 US disclosed
US-9725452-B2 Substituted indoles and pyrroles as RIP kinase inhibitors PRESIDENTS AND FELLOWS OF HARVARD COLLEGE (US) 2017-08-08 US disclosed
US-9586880-B2 Small molecule inhibitors of necroptosis PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-03-07 US disclosed
EP-3034494-A1 HETEROCYCLIC INHIBITORS OF NECROPTOSIS President and Fellows of Harvard College (US) 2016-06-22 EP disclosed
US-20160102053-A1 HETEROCYCLIC INHIBITORS OF NECROPTOSIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-04-14 US disclosed
EP-3000468-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS President and Fellows of Harvard College (US) 2016-03-30 EP disclosed
US-20160031812-A1 SEPIAPTERIN REDUCTASE INHIBITORS FOR THE TREATMENT OF PAIN SOLACE PHARMACEUTICALS UK LTD. (GB) 2016-02-04 US disclosed
US-20160024098-A1 HYBRID NECROPTOSIS INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-01-28 US disclosed
US-20120122889-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-05-17 US disclosed
WO-2012012156-A1 METHODS AND COMPOSITIONS FOR THE IMPROVEMENT OF SKELETAL MUSCLE FUNCTION IN A MAMMAL MYOMICS, INC. (US) 2012-01-26 WO disclosed
US-20110144087-A1 SHORT ACTING BENZOTHIAZEPINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF MILESTONE PHARMACEUTICALS INC. (CA) 2011-06-16 US disclosed
EP-2330895-A1 SHORT ACTING BENZOTHIAZEPINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF Milestone Pharmaceuticals Inc. (CA) 2011-06-15 EP disclosed
WO-2011047156-A1 SEPIAPTERIN REDUCTASE INHIBITORS FOR THE TREATMENT OF PAIN HERCULES TECHNOLOGY MANAGEMENT CO V, INC. (US) 2011-04-21 WO disclosed
US-20100317701-A1 HETEROCYCLIC INHIBITORS OF NECROPTOSIS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-12-16 US disclosed
EP-2192838-A1 HETEROCYCLIC INHIBITORS OF NECROPTOSIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-06-09 EP disclosed
WO-2010022259-A1 SHORT ACTING BENZOTHIAZEPINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF MILESTONE PHARMACEUTICALS INC. (CA) 2010-02-25 WO disclosed
US-20090099242-A1 Heterocyclic inhibitors of necroptosis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-04-16 US disclosed
WO-2009023272-A1 HETEROCYCLIC INHIBITORS OF NECROPTOSIS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2009-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031812-A1 SEPIAPTERIN REDUCTASE INHIBITORS FOR THE TREATMENT OF PAIN SPR, QDPR, SRR AHR 777/4885CA1 4401/4885CA4 4531/4885
US-20120122889-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS TNF, TNFRSF1A, RIPK1 AHR 3528/4885CA1 3356/4885CA4 3987/4885
US-20160102053-A1 HETEROCYCLIC INHIBITORS OF NECROPTOSIS TNF, RIPK1, RIPK3 AHR 2014/4885CA1 2546/4885CA4 4182/4885
US-20170305824-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS TNF, TNFRSF1A, RIPK1 AHR 3545/4885CA1 3414/4885CA4 3999/4885
US-20100317701-A1 HETEROCYCLIC INHIBITORS OF NECROPTOSIS TNF, RIPK1, RIPK3 AHR 2014/4885CA1 2546/4885CA4 4182/4885
US-20110144087-A1 SHORT ACTING BENZOTHIAZEPINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF RYR2, ORAI1, RYR1 AHR 2219/4885CA1 1577/4885CA4 1397/4885
US-20190135718-A1 SMALL MOLECULE INHIBITORS OF NECROPTOSIS TNF, TNFRSF1A, RIPK1 AHR 3545/4885CA1 3414/4885CA4 3999/4885
US-20090099242-A1 Heterocyclic inhibitors of necroptosis TNF, RIPK1, RIPK3 AHR 2014/4885CA1 2546/4885CA4 4182/4885
US-20160024098-A1 HYBRID NECROPTOSIS INHIBITORS RIPK3, RIPK1, RIPK4 AHR 4272/4885CA1 3149/4885CA4 3973/4885
US-10059664-B2 Sepiapterin reductase inhibitors for the treatment of pain SPR, QDPR, SRR AHR 777/4885CA1 4401/4885CA4 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.